|Age:||3 to 21 years old|
|Keywords:||Medulloblastoma, Average-Risk WNT-Driven Medulloblastoma|
|Type:||Drug study, Phase 2|
The study team will make sure you qualify to take part in the study. Qualified participants will receive detailed information about the study. This may include a list of study-related tests and procedures.
= 16 years of age: max serum creatinine 1.7 mg/dL (males) and 1.4 mg/dL (females)
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.